Status:
COMPLETED
IOTA Ultrasound Criteria and Serum CA 125 for Ovarian Malignancy Detection
Lead Sponsor:
Maharajgunj Medical Campus
Conditions:
Ovarian Neoplasms
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
This cross-sectional analytic study assessed the diagnostic accuracy of IOTA Simple Rules versus serum CA 125 in women with adnexal masses undergoing surgery. Eighty-two percent of tumors were classif...
Detailed Description
All women admitted to the Department of Obstetrics and Gynecology and assigned for the surgery of adnexal mass were enrolled in the study. After written informed consent, the clinical proforma was fil...
Eligibility Criteria
Inclusion
- All age groups and parity with ovarian mass admitted for scheduled surgery.
Exclusion
- Proven cases of ovarian malignancy
- Ovarian mass in pregnancy
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06977334
Start Date
January 1 2022
End Date
December 31 2022
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nobel Medical College Teaching Hospital
Biratnagar, Koshi, Nepal, 56700